FDA Inspection
Sumitomo Dainippon Pharma Co., Ltd.Sumitomo Dainippon Pharma Co., Ltd. – FDA Inspection, Aug 7, 2025
Record Details
This FDA Inspection record concerns Sumitomo Dainippon Pharma Co., Ltd., with an inspection on August 7, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 43625239-cfee-4173-8772-0af3efdf143c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1277764
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.68(b)Backup file not maintained
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.84(b)Representative Samples Criteria
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sumitomo Dainippon Pharma Co., Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 27, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 9, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 1, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sumitomo Dainippon Pharma Co., Ltd.
- FDA Inspection 1113228 - 2019-11-22
- FDA Inspection 1064584 - 2018-07-27
- FDA Inspection 990466 - 2016-09-09
- FDA Inspection 853865 - 2013-11-01
- FDA Inspection 770009 - 2012-02-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.